Results 201 to 210 of about 346,412 (355)
Concurrent Nasal Sebaceous Carcinoma and Right-Hand Squamous Cell Carcinoma: A Case Report and Literature Review. [PDF]
Yang Y.
europepmc +1 more source
Two distinct host-specialized fungal species cause white-nose disease in bats
Nicola M. Fischer +12 more
openalex +1 more source
ABSTRACT Introduction Temperature‐controlled radiofrequency (TCRF), septoplasty (ST) with turbinate reduction, and functional rhinoplasty (FR) are treatment options for nasal airway obstruction (NAO) and nasal valve dysfunction (NVD), but no direct comparison of these procedures has been performed. Methods This prospective, open‐label, non‐inferiority (
Greg Davis +13 more
wiley +1 more source
A Rare Clinical Pattern: Acquired Dermal Melanocytosis of Nose. [PDF]
Demir BM, Öztürk F, Sarıcaoğlu H.
europepmc +1 more source
Extent of Sinus Surgery Is Associated With Disease Control in Biologic Treated Type 2 Dominant CRS
ABSTRACT Background A greater benefit of biologics is observed after surgery in Type 2 chronic rhinosinusitis with nasal polyps (CRSwNP). However, the extent of surgery remains undefined in many studies. This study evaluated the extent of surgery on disease control in patients receiving biologics for refractory Type 2 dominant CRSwNP.
Nicholas J. Campion +11 more
wiley +1 more source
Patient-Reported Perceptions of Nasal Aesthetic and Functional Changes Following Le Fort I Osteotomy: A Postoperative Survey-Based Study. [PDF]
Tanrısever NC, Akçam MO.
europepmc +1 more source
A Method for the Determination of the Pus in Diseases of the Accessory Cavities of the Nose.
Henry Horn
openalex
A Simplified Insufflator for Use in the Treatment of Diseases of the Throat, Nose, and Ear.
W. Jobson Horne
openalex +2 more sources
ABSTRACT Background Chronic rhinosinusitis with nasal polyp (CRSwNP) is a heterogeneous Type 2 inflammatory disease characterized by enhanced eosinophilic infiltration. Both innate and adaptive immunity are involved in the onset and progression of CRSwNP.
Yuki Sonoda +4 more
wiley +1 more source

